Girls ages 9 to 13 who received two doses of human papillomavirus vaccine six months apart had the same levels of antibodies against two HPV strains as 16- to 26-year-olds who were given three doses, Canadian researchers found. However, they noted that preteens in the three-dose schedule were more protected against the virus two years after taking the last shot compared with preteens who just had two doses. The findings appear in the Journal of the American Medical Association.
2 doses of HPV vaccine may be as effective as 3 in preteens
SmartBrief Job Listings for Health Care
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Director of Clinical Research||
Regenesis Biomedical, Inc.
Meridian Health Plan
|Assistant Vice President - Dental Director||